Ji-Xin Zhong (Jixin Zhong)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 26

Top Venues

Journal of immunology research

Annals of the rheumatic diseases

Pharmacological reviews

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Case Western Reserve University

Huazhong University of Science and Technology Tongji Medical College (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Case Western Reserve University Nov 01 2016

United States

Assistant Professor (Tenure-Track)

University of Maryland Baltimore Jan 01 2015 - Oct 31 2016

United States

Assistant Professor :: Department of Medicine

University of Maryland Baltimore Dec 01 2013 - Dec 31 2014

United States

Postdoctoral Fellow :: Department of Medicine

Ohio State University Jan 02 2011 - Nov 30 2013

United States

Postdoctoral Researcher :: Davis Heart and Lung Institute

Georgia Regents University Medical College of Georgia May 01 2010 - Jan 02 2011

United States

Postdoctoral Fellow :: Center for Biotechnology and Genomic Medicine

Georgia Regents University Medical College of Georgia Apr 10 2007 - Apr 30 2010

United States

Research Assistant :: Center for Biotechnology and Genomic Medicine

Education History

Huazhong University of Science and Technology Tongji Medical College Sep 01 2004 - Jun 30 2009

China

PHD :: Immunology

Publications

Zhiwen Huang, Zachary Braunstein, Jun Chen, Yingying Wei, Xiaoquan Rao, Lingli Dong, Ji-Xin Zhong
Precision Medicine in Rheumatic Diseases: Unlocking the Potential of Antibody-Drug Conjugates. Pharmacological reviews 76 (4) (2024)
Zhiwen Huang, Zachary Braunstein, Jun Chen, Yingying Wei, Xiaoquan Rao, Lingli Dong, Ji-Xin Zhong
Precision Medicine in Rheumatic Diseases: Unlocking the Potential of Antibody-Drug Conjugates. Pharmacological reviews (2024)
Zhiwen Huang, Zachary Braunstein, Jun Chen, Yingying Wei, Xiaoquan Rao, Lingli Dong, Ji-Xin Zhong
Precision Medicine in Rheumatic Diseases: Unlocking the Potential of Antibody-Drug Conjugates. Pharmacological reviews 76 (4) (2024)
Xiaoquan Rao, Michael Razavi, Georgeta Mihai, Yingying Wei, Zachary Braunstein, Matthew B Frieman, Xiao Jian Sun, Quan Gong, Jun Chen, Gang Zhao, Zheng Liu, Michael J Quon, Lingli Dong, Sanjay Rajagopalan, Ji-Xin Zhong
Dipeptidyl Peptidase 4/Midline-1 Axis Promotes T Lymphocyte Motility in Atherosclerosis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (9) (2023)
Xiaoquan Rao, Michael Razavi, Georgeta Mihai, Yingying Wei, Zachary Braunstein, Matthew B Frieman, Xiao Jian Sun, Quan Gong, Jun Chen, Gang Zhao, Zheng Liu, Michael J Quon, Lingli Dong, Sanjay Rajagopalan, Ji-Xin Zhong
Dipeptidyl Peptidase 4/Midline-1 Axis Promotes T Lymphocyte Motility in Atherosclerosis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (9) (2023)
Yuanji Dong, Rongfen Gao, Kailin He, Ji-Xin Zhong, Lingli Dong
The Role of the IL-33/ST2 Axis in CpG-Induced Macrophage Activation Syndrome. Journal of immunology research 2023 (2023)
Xiaoquan Rao, Michael Razavi, Georgeta Mihai, Yingying Wei, Zachary Braunstein, Matthew B Frieman, Xiao Jian Sun, Quan Gong, Jun Chen, Gang Zhao, Zheng Liu, Michael J Quon, Lingli Dong, Sanjay Rajagopalan, Ji-Xin Zhong
Dipeptidyl Peptidase 4/Midline-1 Axis Promotes T Lymphocyte Motility in Atherosclerosis. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Shaozhe Cai, Zi-Wei Hu, Yu Chen, Yuxue Chen, Bingxia Ming, Rongfen Gao, Zhen Li, Cong Ye, Ji-Xin Zhong, Lingli Dong
BLyS/APRIL dual inhibition for IgG4-RD: a prospective single-arm clinical trial of telitacicept. Annals of the rheumatic diseases (2023)
Zhiqian Bai, Chuanyu Hu, Ji-Xin Zhong, Lingli Dong
Prevalence and Risk Factors of Monoclonal Gammopathy in Patients with Autoimmune Inflammatory Rheumatic Disease: A Systematic Review and Meta-Analysis. Modern rheumatology (2022)
Yuanji Dong, Bingxia Ming, Rongfen Gao, Qian Mo, Xuefen Wu, Fang Zheng, Ji-Xin Zhong, Lingli Dong
The IL-33/ST2 Axis Promotes Primary Sjögren's Syndrome by Enhancing Salivary Epithelial Cell Activation and Type 1 Immune Response. Journal of immunology (Baltimore, Md. : 1950) 208 (12) (2022)
Rongfen Gao, Jungen Tang, Yuanji Dong, Bingxia Ming, Zhihua Yu, Ji-Xin Zhong, Lingli Dong
The Aberrant Levels of Decorin Induce Damages of Human Salivary Gland Epithelial Cells and Polarization of Macrophages. Modern rheumatology (2022)
Rui Song, Hang Qian, Yunlian Wang, Qingmei Li, Dongfeng Li, Jishun Chen, Jingning Yang, Ji-Xin Zhong, Handong Yang, Xinwen Min, Hao Xu, Yong Yang, Jun Chen
Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists. Journal of diabetes research 2022 (2022)
Zichu Zhao, Yanli Huang, Bingxia Ming, Ji-Xin Zhong, Lingli Dong
Characterization and associated risk factors of Pneumocystis jirovecii pneumonia in patients with AIRD: a retrospective study. Rheumatology (Oxford, England) 61 (9) (2022)
Michael Razavi, Ying-Ying Wei, Xiao-Quan Rao, Ji-Xin Zhong
DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits. Military Medical Research 9 (1) (2022)
Yuanji Dong, Ji-Xin Zhong, Lingli Dong
The Role of Decorin in Autoimmune and Inflammatory Diseases. Journal of immunology research 2022 (2022)
Ting Zheng, Xinxin Liu, Yingying Wei, Xinlu Li, Bing Zheng, Quan Gong, Lingli Dong, Ji-Xin Zhong
Laboratory Predictors of COVID-19 Mortality: A Retrospective Analysis from Tongji Hospital in Wuhan. Mediators of inflammation 2021 (2021)
Li Yang, Long Chen, Dongfeng Li, Hao Xu, Jishun Chen, Xinwen Min, Meian He, Tangchun Wu, Ji-Xin Zhong, Handong Yang, Jun Chen
Effect of GLP-1/GLP-1R on the Polarization of Macrophages in the Occurrence and Development of Atherosclerosis. Mediators of inflammation 2021 (2021)
Ji-Xin Zhong, Cong Ye, Shaozhe Cai, Lingli Dong
Response to: 'Comment on Ye et al 'Presence of respiratory failure of COVID-19 infection in patients with rheumatism in Wuhan, China'' by Chen et al. Annals of the rheumatic diseases (2020)
Cong Ye, Shaozhe Cai, Guifen Shen, Hanxiong Guan, Liling Zhou, Yangyang Hu, Wei Tu, Yu Chen, Yikai Yu, Xuefen Wu, Yuxue Chen, Ji-Xin Zhong, Lingli Dong
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China. Annals of the rheumatic diseases 79 (8) (2020)
Yingying Wei, Linan Peng, Yi Li, Na Zhang, Ke Shang, Lihua Duan, Ji-Xin Zhong, Jie Chen
Higher Serum CCN3 Is Associated with Disease Activity and Inflammatory Markers in Rheumatoid Arthritis. Journal of immunology research 2020 (2020)
Ji-Xin Zhong, Lingli Dong
Response to: 'Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia' by Wan et al. Annals of the rheumatic diseases (2020)
Mengyun Duan, Yuan Yang, Shuang Peng, Xiaoqin Liu, Ji-Xin Zhong, Yurong Guo, Min Lu, Hao Nie, Bo Xu Ren, Xiangzhi Zhang, Lian Liu
C/EBP Homologous Protein (CHOP) Activates Macrophages and Promotes Liver Fibrosis in Schistosoma japonicum-Infected Mice. Journal of immunology research 2019 (2019)
Chang Xia, Aditya Goud, Jason D'Souza, CHanukya Dahagam, Xiaoquan Rao, Sanjay Rajagopalan, Ji-Xin Zhong
DPP4 inhibitors and cardiovascular outcomes: safety on heart failure. Heart failure reviews 22 (3) (2018)
Xiaoxia Fu, Fei Sun, Fa Xi Wang, Junai Zhang, Biying Zheng, Ji-Xin Zhong, Tian-Tian Yue, Xuebao Zheng, Jun-Fa Xu, Cong-Yi Wang
Aloperine Protects Mice against DSS-Induced Colitis by PP2A-Mediated PI3K/Akt/mTOR Signaling Suppression. Mediators of inflammation 2017 (2017)
Chang Xia, Xiaoquan Rao, Ji-Xin Zhong
Role of T Lymphocytes in Type 2 Diabetes and Diabetes-Associated Inflammation. Journal of diabetes research 2017 (2017)
Xiaoquan Rao, Jeffrey A Deiuliis, Jeffrey A Deiuliis, Juliet Varghese, Chang Xia, Matthew B Frieman, Carole Sztalryd, Xiao Jian Sun, Michael J Quon, Simeon I Taylor, Sanjay Rajagopalan, Ji-Xin Zhong
Monocyte DPP4 Expression in Human Atherosclerosis Is Associated With Obesity and Dyslipidemia. Diabetes care 41 (1) (2017)

Ji-Xin Zhong.css-eqlu8i{font-size:small;padding-left:4px;} (Jixin Zhong)

Publication Activity (10 Years)

Top Topics

Top Venues

Ji-Xin Zhong (Jixin Zhong)